Does VORAPAXAR Cause Haemoglobin decreased? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Haemoglobin decreased have been filed in association with VORAPAXAR. This represents 2.7% of all adverse event reports for VORAPAXAR.
5
Reports of Haemoglobin decreased with VORAPAXAR
2.7%
of all VORAPAXAR reports
0
Deaths
3
Hospitalizations
How Dangerous Is Haemoglobin decreased From VORAPAXAR?
Of the 5 reports, 3 (60.0%) required hospitalization.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VORAPAXAR. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does VORAPAXAR Cause?
Gastrointestinal haemorrhage (15)
Epistaxis (11)
Chest pain (8)
Death (8)
Drug dose omission (8)
Haemorrhage (7)
Dyspnoea (6)
Malaise (5)
Rash (5)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which VORAPAXAR Alternatives Have Lower Haemoglobin decreased Risk?
VORAPAXAR vs VORASIDENIB
VORAPAXAR vs VORETIGENE NEPARVOVEC-RZYL
VORAPAXAR vs VORICONAZOLE
VORAPAXAR vs VORINOSTAT
VORAPAXAR vs VORTIOXETINE